We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.

How a drug approval changed the lives of patients living with rare disease.

Defining the best strategies for working with highly potent drug substances.

An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

Embracing the benefits of auto-injectors.

What milestones will define the next era in the mRNA story?

Welcome to our Special Series E-book on Advanced Medicine!

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.